AET - Aetna Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
0.0000
0.0000 (0.33%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close0.0000
Open212.5700
Bid0.00 x 1100
Ask0.00 x 900
Day's Range211.7900 - 213.3600
52 Week Range166.8900 - 213.3600
Volume11,862,705
Avg. Volume2,807,873
Market Cap0
Beta (3Y Monthly)0.89
PE Ratio (TTM)0.00
EPS (TTM)11.12
Earnings DateJan 28, 2019 - Feb 1, 2019
Forward Dividend & Yield2.00 (0.97%)
Ex-Dividend Date2018-10-23
1y Target Est208.31
Trade prices are not sourced from all markets
  • CVS defends settlement that allowed Aetna merger as judge assesses
    Reuters14 hours ago

    CVS defends settlement that allowed Aetna merger as judge assesses

    CVS Health Corp (CVS.N) defended on Friday an agreement with the U.S. Justice Department which allowed it to purchase health insurer Aetna for $69 billion, a settlement that a federal judge is still assessing. The Justice Department approved the merger of CVS, a U.S. pharmacy chain and benefits manager, and Aetna in October on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans Inc (WCG.N). Now, the Justice Department and companies have found themselves in the unusual position of defending their antitrust settlement to a skeptical federal judge.

  • CVS defends settlement that allowed Aetna merger as judge assesses
    Reuters14 hours ago

    CVS defends settlement that allowed Aetna merger as judge assesses

    The Justice Department approved the merger of CVS, a U.S. pharmacy chain and benefits manager, and Aetna in October on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans Inc . Now, the Justice Department and companies have found themselves in the unusual position of defending their antitrust settlement to a skeptical federal judge. In its brief, filed on Friday, CVS said that the deal had been extensively reviewed and urged the judge to allow the companies to continue integrating while he examines the settlement reached with the government.

  • Motley Fool22 hours ago

    Ask a Fool: What Should I Do if a Company Whose Stock I Own Gets Acquired?

    The right answer depends on the details of the acquisition.

  • CNBC22 hours ago

    Goldman downgrades Walgreens' stock to rare 'sell,' shares fall

    Goldman analyst Robert Jones said he doesn't think Walgreens' numerous partnerships with other companies will help offset declines in its core retail pharmacy business. He downgraded Walgreens to "sell" ...

  • Asian shares fall on poor Chinese economic data
    Associated Pressyesterday

    Asian shares fall on poor Chinese economic data

    SINGAPORE (AP) — Asian markets tumbled on Friday after China reported weaker-than-expected economic data, stirring up worries about the state of the world's second largest economy.

  • Associated Press2 days ago

    CVS and Delta fall while Aflac and General Electric jump

    Stocks that moved substantially or traded heavily Thursday: CVS Health Corp., down $1.13 to $73.37 The New York Post reported that a judge might bar CVS from integrating its business with health insurer ...

  • TheStreet.com2 days ago

    U.S. Stocks Close Mixed After Late Rally; GE, P&G Gain

    The Dow Jones Industrial Average rose Thursday as Wall Street expressed optimism over U.S. and China trade talks. said Thursday it would invest $1 billion to build a new campus in Austin, Texas. Stocks traded mixed on Thursday, Dec. 13, as Wall Street monitored trade developments between the U.S. and China, the world's two largest economies.

  • Motley Fool2 days ago

    Top 10 Healthcare Stories of 2018

    New drugs, trial flops, M&A, and a little bit of everything else that happened in healthcare in 2018.

  • TheStreet.com2 days ago

    Apple, Adobe, Huawei, CVS and Boy Scouts - 5 Things You Must Know

    U.S. stock futures were mixed on Thursday, Dec. 13, and shares in Asia closed higher as trade tensions eased between the U.S. and China, the world's two largest economies. Wall Street finished higher on Wednesday, Dec. 12, as investors cheered progress in U.S.-China trade talks and after a report said China was planning a new program that promised greater access for foreign companies. The Wall Street Journal reported Wednesday that China was drafting a replacement for Made in China 2025 - President Xi's blueprint to make the country a leader in high-tech industries - which would play down China's bid to dominate manufacturing and be more open to participation by foreign companies.

  • CNBC3 days ago

    In acquiring Aetna, CVS embarks on another pivotal moment in its 55-year history

    CVS Health acquired health insurance giant Aetna for about $70 billion. CVS has bought other pharmacies to build its footrprint, as well as pharmacy benefit manager Caremark and walk-in health clinic MinuteClinic. It's buying a health insurer to prove it.

  • TheStreet.com4 days ago

    Expect Less M&A in 2019 as Big Year Comes to a Close

    To start 2018, many on Wall Street were predicting a great year for stocks, as Donald Trump's tax plan was expected to produce elevated mergers and acquisitions activity. The deal activity has certainly been a part of the 2018 story, but the trend could slow down in 2019, said analysts from Goldman Sachs. Deal announcements are expected to increase 20% year over year in 2018, according to a note from Goldman that was released Tuesday.

  • CNBC4 days ago

    Stocks making the biggest moves premarket: DSW, F, GM, CVS, PFE & more

    These are the stocks posting the largest moves before the bell.

  • The Wall Street Journal9 days ago

    [$$] Walgreens Launches Next-Day Prescription Home Delivery With FedEx

    Walgreens Boots Alliance Inc. has teamed up with FedEx Corp. to launch a nationwide next-day prescription home-delivery service as the drugstore chain works to stave off competition from Amazon.com Inc. and other rivals. Under the delivery service called Walgreens Express, patients enrolled in text alerts will receive text notification when qualifying prescriptions are ready, Walgreens said Thursday. For a $4.99 fee, patients can have their prescriptions delivered by FedEx to their home as early as the next day.

  • Walgreens expands prescription delivery program nationwide
    Associated Press9 days ago

    Walgreens expands prescription delivery program nationwide

    Walgreens is joining rival drugstore chain CVS Health in expanding home deliveries for prescriptions nationwide, as stores continue adjusting to a retail world made more consumer-friendly by online competition. Walgreens said Thursday it will partner with FedEx to deliver prescriptions as soon as the next day for a $4.99 fee, and it also is providing same-day deliveries in several cities including New York, Chicago and Dallas. Walgreens and FedEx Corp. began a partnership last year where the drugstore chain started offering package drop-off and pick-up services at several thousand stores.

  • CNBC9 days ago

    Stocks making the biggest moves premarket: FB, GOOG, SIG, CVS, THO & more

    These are the stocks posting the largest moves before the bell.

  • CVS Hears Trump, But Don't Count on Lower Drug Prices
    Bloomberg10 days ago

    CVS Hears Trump, But Don't Count on Lower Drug Prices

    The company announced a new pricing model for its pharmacy benefit management services Wednesday morning. The White House has been an active critic of PBMs, which negotiate drug discounts on behalf of employers and health plans, arguing that they have distorted the drug-pricing system. Drugmakers pay rebates than can amount to more than 50 percent of a drug’s sticker price to secure favorable coverage on PBM drug lists, and critics contend that firms like CVS keep an excessive slice of those undisclosed payments.

  • CNBC10 days ago

    CVS CEO has a fix for those mile-long receipts — here's how it works

    "There's a way to get all of that digitally on your phone," along with the coupons and extra bucks rewards, CVS CEO Larry Merlo tells CNBC's Bertha Coombs.

  • TheStreet.com10 days ago

    CVS Health to Roll Out New Drug Pricing Model

    The new model will allow CVS Caremark to pass through 100% of drug rebates to its health plan clients.

  • CVS offers 'guaranteed net cost' for pharmacy benefit clients
    Reuters10 days ago

    CVS offers 'guaranteed net cost' for pharmacy benefit clients

    The "guaranteed net cost" option could also deflect growing criticism that pharmacy benefit managers (PBMs) reap gains off the widening gap between pharmaceutical list prices and their lower net cost after hefty rebates paid by drugmakers to secure coverage and access to their products. President Donald Trump, who has promised lower prescription drug costs for U.S. consumers, earlier this year singled out industry "middlemen", such as PBMs and insurers, and the common practice of drugmakers offering rebates to them.

  • U.S. judge concerned over government nod for CVS-Aetna deal
    Reuters11 days ago

    U.S. judge concerned over government nod for CVS-Aetna deal

    A federal judge who has been asked to sign off on the U.S. government's decision to approve CVS Health Corp's (CVS.N) acquisition of insurer Aetna Inc said Tuesday he was "less convinced" than the government that the companies had struck a deal that ensured the merger was legal under antitrust law. Judge Richard Leon of the U.S. District Court for the District of Columbia had complained last week in a hearing that the two sides had treated him as a "rubber stamp" for the agreement. "At this stage, I am less convinced of the sufficiency of the government's negotiated remedy than the government is," he wrote in the order issued on Tuesday.

  • The Wall Street Journal12 days ago

    [$$] Federal Judge Voices Concerns About Justice Dept. Approval of CVS-Aetna Deal

    WASHINGTON—A federal judge on Monday sharply questioned the Justice Department’s decision to green-light CVS Health Corp.’s nearly $70 billion acquisition of Aetna Inc., and said he may order CVS to halt its integration of Aetna’s assets while he considers the merger’s implications. It is highly unusual for a judge to make such an announcement, since Justice Department antitrust enforcers had approved the deal in October under the condition the companies sell Aetna’s Medicare drug business to preserve competition. When the Justice Department identifies concerns with a merger—and reaches an agreement with the merging companies to address them—a federal law called the Tunney Act requires the government to file the proposed settlement for approval by a federal court, which determines whether the deal is in the public interest.

  • CNBC12 days ago

    What a judge can — and can't — do in ruling on the Justice Department's deal with CVS and Aetna

    Judge Richard Leon is considering halting the integration of CVS Health and Aetna. CVS and Aetna closed their roughly $70 billion merger on Nov. 28. The Justice Department's agreement with the companies needs to be approved by a judge but cannot be blocked outright, legal experts say.

  • CVS Ordered by U.S. Judge to Defend Consummating Aetna Deal
    Bloomberg12 days ago

    CVS Ordered by U.S. Judge to Defend Consummating Aetna Deal

    U.S. District Judge Richard Leon in Washington set a hearing for Dec. 18 where he will consider ordering the companies to keep their assets separate until he weighs approval of the antitrust settlement with the government, a process that could take months. The ruling complicates CVS’s plans for the Aetna acquisition, a $68 billion deal that creates a health-care giant with a hand in insurance, prescription-drug benefits and drugstores across the U.S. CVS closed the takeover on Nov. 28 after obtaining final regulatory approvals and now faces the prospect that its plans for the combined company will be put on hold. “CVS Health and Aetna are one company, and our focus is on transforming the consumer health experience,” CVS said in a statement, without commenting further.